This site is intended for a global audience
Contact Us

Leader Perspectives

Kelvin Tan, MB BCh, MRCPCH, Senior Vice President and Chief Medical Officer

As we gear up for ASCO 2023, our team at Jazz is energized by the opportunity to share our research and learn about the latest advancements in cancer care, including difficult-to-treat cancers like small cell lung cancer (SCLC). It’s also an opportunity to highlight the importance of incorporating patients’ perspectives into our R&D process and supporting them and their families beyond treatment. 

Bruce Cozadd, Chairman and Chief Executive Officer

March is an important month for us at Jazz. As a leader in sleep medicine, the month served as an awareness opportunity for those living with sleep disorders, as well as their caregivers, healthcare providers and our advocacy partners.

Kelvin Tan, Senior Vice President, Chief Medical Officer & Head of Development

Jazz is committed to developing critical medicines for people living with serious neurological conditions including epilepsy. At this year’s 2022 American Epilepsy Society (AES) annual meeting, we will present data from six abstracts showcasing Jazz’s commitment to providing medicines for people living with rare forms of epilepsy with few treatment options.

Bruce Cozadd

In recognition of National Epilepsy Awareness Month, our Chief Executive Officer, Bruce Cozadd shares Jazz’s commitment to raising awareness of epilepsy and how we’re working to generate a greater impact and address the needs of the epilepsy community.

Kim Sablich

This year’s World Heart Day is centered around the theme of ‘Cardiovascular Health for Everyone,’ which raises awareness of the prevention, treatment and management of cardiovascular disease worldwide. At Jazz, we know that people living with sleep disorders, such as narcolepsy, face risks in developing some of these comorbidities, and we are committed to exploring solutions that can help effectively manage the impacts they face, including hypertension, cardiovascular disease, obesity and diabetes.

Abizer Gaslightwala

In honor of Blood Cancer Awareness Month, Abizer Gaslightwala Vice President, Head of US Hematology/Oncology Business Unit at Jazz, reflects on Jazz’s commitment to patients with blood cancer and the unique partnership with a childhood cancer research group that enabled the accelerated development process of a new treatment option for some blood cancer patients to ensure reliable access to treatment without obstacles to their care.